Summary Glucose production and utilization and activities of key enzymes involved in liver and muscle glucose metabolism were studied in post-absorptive streptozotocin-diabetic rats after 12h of severe hyperglycaemia (17.5 + 0.5 mmol/1) and insulinopenia (5 + 1 ~tU/ml). Basal glucose production was increased: 36.6 + 3.0 mg. kg. min -1, vs 24.4 + 2.5 in controls (p < 0.05); liver glycogen concentration was decreased by 40 % (p < 0.05); liver phosphoenolpyruvate carboxykinase and glucose-6-phosphatase activities were increased by 375 and 156 %, respectively (/7 < 0.001 and < 0.01). During a euglycaemic clamp at a plasma insulin level of 200 ~U/ml, glucose production was totally suppressed in controls, but persisted at 20 % of basal in diabetic rats. In these rats, glucose production was suppressed at a plasma insulin level of 2500 ~tU/ml. Basal whole body glucose utilization rate, 2-deoxy-l-[3H]-D-glucose ([3H]-2DG) uptake by muscles and muscle glycogen concentrations were similar in both groups, as well as total and active forms of pyruvate dehydrogenase and glycogen synthase activities. During the euglycaemic clamp, the total body glucose utilization rates and [3H]-2DG uptake by muscles were similar in control and diabetic rats at a plasma insulin level of 200 ~tU/ ml, but lower in diabetic rats at a plasma insulin level of 2500 ~tU/ml. We conclude 1) in recent-onset severely insulinopenic rats, an excessive glucose production via gluconeogenesis prevailed, mainly accounting for the concomitant hyperglycaemia. This excess glucose output cannot be attributed to liver insulin resistance: the gluconeogenic pathway is physiologically less sensitive than glycogenolysis to the inhibition by insulin. 2) Glucose utilization was apparently normal under hyperglycaemic conditions and at a lower insulin plateau of the euglycaemic clamp but suboptimal in the presence of maximal insulin concentrations, suggesting an early appearance of peripheral insulin resistance. [Diabetologia (1995) 38: 283-290] 
Summary Glucose production and utilization and activities of key enzymes involved in liver and muscle glucose metabolism were studied in post-absorptive streptozotocin-diabetic rats after 12h of severe hyperglycaemia (17.5 + 0.5 mmol/1) and insulinopenia (5 + 1 ~tU/ml). Basal glucose production was increased: 36.6 + 3.0 mg. kg. min -1, vs 24.4 + 2.5 in controls (p < 0.05); liver glycogen concentration was decreased by 40 % (p < 0.05); liver phosphoenolpyruvate carboxykinase and glucose-6-phosphatase activities were increased by 375 and 156 %, respectively (/7 < 0.001 and < 0.01). During a euglycaemic clamp at a plasma insulin level of 200 ~U/ml, glucose production was totally suppressed in controls, but persisted at 20 % of basal in diabetic rats. In these rats, glucose production was suppressed at a plasma insulin level of 2500 ~tU/ml. Basal whole body glucose utilization rate, 2-deoxy-l-[3H]-D-glucose ([3H]-2DG) uptake by muscles and muscle glycogen concentrations were similar in both groups, as well as total and active forms of pyruvate dehydrogenase and glycogen synthase activities. During the euglycaemic clamp, the total body glucose utilization rates and [3H]-2DG uptake by muscles were similar in control and diabetic rats at a plasma insulin level of 200 ~tU/ ml, but lower in diabetic rats at a plasma insulin level of 2500 ~tU/ml. We conclude 1) in recent-onset severely insulinopenic rats, an excessive glucose production via gluconeogenesis prevailed, mainly accounting for the concomitant hyperglycaemia. This excess glucose output cannot be attributed to liver insulin resistance: the gluconeogenic pathway is physiologically less sensitive than glycogenolysis to the inhibition by insulin. 2) Glucose utilization was apparently normal under hyperglycaemic conditions and at a lower insulin plateau of the euglycaemic clamp but suboptimal in the presence of maximal insulin concentrations, suggesting an early appearance of peripheral insulin resistance. [Diabetologia (1995) 38: 283-290] when beta-cell destruction is the primary cause of hyperglycaemia, insulin resistance develops secondarily [4] . Both glucose overproduction and underutilization then contribute to the pathophysiology of hyperglycaemia. At the earliest stage of acute insulin deficiency, the chronology of insulin resistance and its potentially uneven distribution and progression in various insulin-sensitive tissues are still a matter of discussion. Recent-onset IDDM patients studied after a few days of insulin therapy are markedly insulin resistant [5, 6] . Spontaneously diabetic BB rats, studied 24 h after detection of hyperglycaemia, are resistant to insulin, despite normal insulin sensitivity on the previous day [7] . In well-defined streptozoto-cin (STZ) diabetic rats, insulin resistance was detected 48 h or more after the STZ injection, affecting both glucose production and glucose utilization [8- 12].
The present study was designed to clarify the following: 1) what appears first at the earliest stage of STZ-induced insulinopenic diabetes in rats: excessive glucose production by the liver, or decreased glucose utilization by insulin-sensitive tissues? 2) if present, how does resistance to insulin affect the different target tissues ? To this end, unstressed, freely-moving rats, well defined from a metabolic standpoint, were subjected to a euglycaemic hyperinsulinaemic clamp 30 h after STZ treatment, i.e. after 12 h of insulinopenia; total body glucose turnover, glucose utilization by muscles and adipose tissues were determined as well as liver and skeletal muscle glycogen levels, and the activities of key enzymes of glucose metabolism in the post-absorptive state: phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G 6-Pase) in the liver; glycogen synthase and pyruvate dehydrogenase (PDH) in muscle.
Materials and methods
Animals. Syngeneic male Wistar rats (IFFA Credo, L'Arbresle, France) were purchased at a body weight of 180-200 g, housed at 24~ with lights on from 07.00 to 19.00 hours, and free access to water and chow pellets (Extra-labo, Paris, France) (% of energy: carbohydrate 65 %, fat 11%, protein 24 %). At a weight of about 250 g, they were randomly assigned to either the control or STZ-diabetes groups.
Surgical procedures. In order to serially follow the circulating substrate and hormone levels in unstressed conscious rats, indwelling vascular catheters (internal diameter 0.025 in, outer diameter 0.048 inches, Silastic, Dow Coming Co, Midland, Mich., USA) were implanted 24 h before the experiments. Rats were anaesthetized with thiopental (50 mg/kg body weight, IP). The two catheters were implanted into the two jugular veins, filled with heparin solution (20 U/ml), sealed, tunnelled subcutaneously to the back of the neck, externalized through a skin incision and anchored to the skull with a dental cement cap (Pennwalt, Philadelphia, Pa., USA). Care was taken to drive catheters at two different levels: the right cardiac cavities for the sampling catheter, and the upper part of the left jugular vein for the infusion catheter. Contamination of the samples by infusion fluids, which could result in some artefactual overestimation of the [3-3H] glucose enrichment and underestimation of the hepatic glucose production, was thus minimized. Immediately after surgery, rats were housed in individual metabolic cages. They were conscious, undisturbed and unrestrained before and during the study. The recovery after surgery was rapid. Food intake during the night preceding clamp experiments was 15-18 g in control rats and 18-20 g in STZ-diabetic rats. Body weight before starting clamp experiments was 95-100 % of pre-operative weight in controls, and 85-95 % in STZ-diabetic rats. Control rats were surgically operated, sham-injected and subjected to the same metabolic investigations as STZ-diabetic rats.
Diabetes induction. Destruction of pancreatic beta-cells was performed by a single i.v. injection of STZ (65 mg/kg body R. Burcelin et al.: Glucose overproduction, minor insulin resistance in recent-onset STZ rats wt), 24 h after catheter implantation. Streptozotocin (Sigma, St Louis, Mo., USA) was dissolved extemporaneously in 0.1 mol/1 cold sodium citrate, pH 4.5. To determine the exact time of onset of hyperglycaemia, venous blood glucose levels were measured every 2 h after the STZ injection, using glucose-oxidase strips (Glucostix; Ames, Elkhart, Ind., USA), read with a reflectance meter (Glucometer II, Ames). The changes in blood metabolites were also analysed up to 72 h in similar STZ-diabetic rats not subjected to clamp experiments.
The time selected for clamp experiments allowed minimization of metabolic and hormonal interferences due to early stress and acute blood glucose variations for the first hours and, later, those due to prolonged hyperglycaemia, excessive plasma non-esterified fatty acid (NEFA) levels among others. Owing to the chronically implanted catheters and the careful follow-up after STZ injection, the rats were metabolically homogeneous, unstressed, awake and freely moving, and had active postural muscles, thus allowing a valid interpretation of glucose turnover data.
Glucose homeostasis in the post-absorptive state
Glucose turnover. Experiments were started 30 h after STZ injection, i.e. 12 h after the onset of significant hyperglyeaemia (7.2 _+ 0.5 mmol/1). Food was withdrawn at 7.00 hours and the experiments were started at 14.00 hours. Under these conditions, blood glucose concentrations were not higher in the portal vein than in the aorta: 17.2 _+ 1.9 mmol/1 and 16.9 + 1.5 mmol/1, respectively [11] , indicating that the gut did not add significant amounts of glucose into the portal circulation from previously ingested food. The rats were thus considered to be in the post-absorptive state, the rate of glucose production was therefore a measure of endogenous glucose formation. Urine was collected for quantification of urinary glucose loss and for measurement of [3-3H] glucose specific activity [13] .
Basal glucose turnover was quantified using a bolus primed
(Amersham International, Amersham, Bucks, UK), which was maintained for 90 min in control rats (n = 5) and diabetic rats (n = 9) [14] . Three samples were collected at 10-min intervals for the last 20 min of the experimental period for measurement of glucose specific activity. It was verified that glucose specific activity was constant in these three samples. Rats in which glucose specific activity changed by more than 10 % during the last 20 min were discarded.
Glucose utilization index in individual tissues.
Glucose utilization index in individual tissues was assessed under basal conditions in six control and six hyperglycaemic STZ-diabetic rats, after an injection of a tracer amount (30 ~tCi) of the non-metabolizable glucose analogue 2-deoxy-l-[3H]-n-glucose ([3H]-2riG) (Centre de l'Energie Nucl6aire, Saclay, France) in 300 ~1 of saline. The slope of [3H]-2DG disappearance from plasma was calculated from samples collected at 1, 3, 7, 10, 20, 30 and 60 rain after [3H]-2DG injection; levels at 60 min were less than 10 % of the 1-min value [15] . One hour after [3H]-2DG administration, the different tissues were sampled for determination of 2-deoxy-l-[3H]-6-phosphate ([3H]-2DGP) content [15] . At the end of the tests, 3 ml of venous blood was collected on 200 ~1 of a mixture of 2000 U/ml aprotinine (Iniprol, Laboratoires Choay, Paris, France) and 0.01 tool/1 EDTA and immediately centrifuged at + 4 ~ Plasma was frozen at -20 ~ until determination of plasma insulin and glucose concentrations, Animals were then killed by an i.v. injection of thiopental (60 mg. kg -1. body weight-I). The following hindquarter muscles were rapidly removed (all within 2 min): soleus (a slow twitch, oxidative muscle), extensor digitorum longus (a fast twitch, glycolytic muscle), diaphragm and heart ventricle. Epididymal and interscapular fat pads were also removed. All tissues were rapidly rinsed in chilled 0.9 % NaC1 solution, frozen in liquid nitrogen and stored at -80 ~ until analysis of [3H]-2DGP content [15] .
Glycogen concentration and enzyme activities. Further control (n = 6) and diabetic (n = 6) rats were killed by cervical dislocation. Samples of the hepatic median lobe of the liver (0.3 g) and of soleus muscle were rapidly frozen and ground in liquid nitrogen for further determination of glycogen concentration. Enzyme activities were measured on fresh homogenates of liver and soleus muscles.
Glucose homeostasis in the euglycaemic hyperinsulinaemic clamp
Glucose turnover. In these experiments, the blood glucose concentration of STZ-diabetic rats was normalized (from 17.5 to 5.5 mmol/1) within the first 30 rain of the experimental period by a primed-continuous insulin infusion. Recent experiments in spontaneously diabetic BB rats have shown that normalization of blood glucose levels within 30 rain by insulin infusion did not increase plasma glucagon and epinephrine plasma levels [7, 16] . Thus, we assume that no counterregulation occurred in STZ-diabetic rats in these experimental conditions.
Two rates of insulin (Actrapid; Novo, Copenhagen, Denmark) infusions were used: 1) either a bolus of 16 mU/kg and then a continuous infusion at a rate of 0.8 U. kg -1. h -1 to obtain a lower plasma insulin steady-state of about 200 ~tU/ml for 90 min (control rats) and 120 min (diabetic rats), the 30-min difference being due to the time necessary for normalization of the blood glucose level in the diabetic rats; or 2) a bolus of 84 mU/kg and then a continuous infusion at a rate of 3.2 U. kg -1. h -1 to obtain a higher plasma insulin steady-state of about 2500 vU/ml. At 5-10 rain intervals, a droplet (20 ~tl) of venous blood was collected for glucose determination. The initial glucose infusion rate was adjusted manually to maintain the blood glucose level around 5.5 mmol/1. Glucose turnover was quantified using the above described primed-continuous [3-3H] glucose infusion, which was maintained for 90 rain in control and 120 min in STZ-diabetic rats. Three blood samples were collected at 10-rain intervals during the last 20 min of the experimental periods for measurement of glucose specific activity. Glucose turnover was quantified during euglycaemic hyperinsulinaemic clamp [14] in 19 control (lower steady-state plasma insulin: n = 10; higher steady-state plasma insulin: n = 13) and 23 diabetic rats (lower steady-state plasma insulin: n = 10; higher steady-state plasma insulin: n = 10).
Glucose utilization index in individual tissues. Glucose utilization index in individual tissues was quantified under clamp conditions in 12 control (lower steady-state plasma insulin: n = 6; higher steady-state plasma insulin: n = 6) and 12 normoglycaemic STZ-diabetic rats (lower steady-state plasma insulin: n = 6; higher steady-state plasma insulin: n = 6), after injection of a tracer amount of [3H]-2DG, as described above. The glucose utilization index was measured during the last 60 rain of euglycaemic hyperinsulinaemic clamps.
Determinations
Substrates and hormones. During clamp experiments, venous blood glucose was determined by the glucose oxidase method using a Beckman glucose analyzer (Beckman BGA2; Galway, Republic of Ireland). Plasma insulin and glucagon concentrations were determined by radioimmunoassay [17] . Insulin was assayed with a kit (Pharmacia, Uppsala, Sweden) including human insulin as standard, an 125I-labelled human insulin tracer and a guinea-pig anti-human-insulin antibody, which cross-reacts similarly with rat insulin. The glucagon assay kit from Pharmacia includes porcine glucagon as standard, a porcine xz~I-labelled glucagon tracer and a rabbit anti-porcine antiserum specific for pancreatic glucagon. NEFA were determined by an enzymic method using an acyl-CoA oxidase-based colourimetric kit (WAKO, NEFA-C, Wako Pure Chemical Industries, Osaka, Japan). Ketonuria was semi-quantitatively estimated by use of Ketodiastix strips (Ames).
Isotope determinations. For 2-deoxy-l-[3H]-D-glucose and [3-
3H] glucose determinations, plasma samples were immediately deproteinized in 5.5 % ZnSO4 and saturated barium hydroxide-zinc sulphate mixture [15] . Glucose was determined in the supernatant by a glucose oxidase method. An aliquot was evaporated to dryness to eliminate tritiated water, and counted in a beta-scintillation counter (Beta-Matic, Kontron, Paris, France). Tissue [3H]-2DGP content was determined as previously described [15] .
Urinary glucose excretion rate. In basal conditions, urinary [3H]-glucose excretion rate in STZ-diabetic rats was obtained by pooling urine obtained by spontaneous micturition and urine obtained from the bladder at the time of killing [13] .
During clamp experiments the urinary [3H]-glucose excreted following the initial 30-min normalization of blood glucose concentration was measured and subtracted from the total urinary [3H]-glucose excreted during the clamp, in order to obtain the net urinary glucose excretion rates under euglycaemic conditions [13] .
Enzyme activities and glycogen. All enzyme activities were carried out at 37 ~ Phosphoenolpyruvate carboxykinase (PEP-CK) activity was determined using the NaH[14C]O3 fixation assay [17] . Results were expressed as nmol of Nail [X4C]O3 fixed per min per milligram of protein. Glucose 6-phosphatase (G 6-Pase) activity was measured by determining the inorganic phosphate formed from Glucose 6-phosphate during a 10-nfin incubation [18] . A 300-rag sample of the main liver lobe was ground in liquid nitrogen and homogenized in 10 ml citrate buffer (0.1 mol/1, pH 6.5). The homogenate was kept less than 30 rain in ice before assay; 100 ~tl was added to 100 ~1 of glucose 6-phosphate (0.08 tool/l) for 10-min at 30 ~ The reaction was stopped by addition of 2 ml trichloracetic acid (10 %). After a 10 min centrifugation at 4000 g, 0.5 ml of the supernatant was mixed with the sulphomolybdic reagent, and the optical density was then compared to that of an inorganic phosphate standard tested in the same conditions. Glycogen synthase activity was measured as described by Rossetti et at. [18] . This assay is based on the incorporation of UDP-[U I4C]glucose into glycogen. One of the two soleus muscles (80 mg) was homogeneized in 2.0 ml of Tris/I-IC1 buffer, pH 7.8, containing 10mmol/1 EDTA, 5retool/1 dithiothreitol, 50 mmol/1 NaF, and 2.5 g/1 rabbit liver glycogen type III. The homogenate was centrifuged at 2,000 g for 15 rain at 4~ and the supernatant used for glycogen synthase assay by measuring the incorporation of UDPG-[UJ4C]glucose into glycogen at 30~
in the presence of a physiologic concentration (0.11 mmol/1) of G6R Total glycogen synthase activity was by centrifugation (10,000 x g), immediately frozen in liquid nitrogen and used for the determination of the total PDH activity (PDHt) (19] . Mitochondria were extracted in extraction buffer (50 mmol/1 potassium phosphate/10 mmol/1 EGTA/2 mmol/l dithiothreitol pH 7.0) for assay of enzyme and protein concentrations by alternate (three times) thawing (30 ~ and freezing in liquid nitrogen. Triton X100 was omitted from the extraction medium and added to the assay buffer in order to avoid interferences with protein determinations. The PDH complex activity in mitochondria extracts was assayed spectrophotometrically by coupling to arylamine acetyltransferase and following the production of acetyl CoA from pyruvate and CoA [2011 One unit of enzyme activity is defined as that which converts 1 ~tmol of pyruvate into acetyl-CoA per rain at 30 ~ Protein concentration was determined by the method of Lowry using bovine serum albumin as a standard.
Glycogen and protein.
Liver and muscle glycogen concentrations were measured according to Rossetti et al. [18] . This method is based on the hydrolysis of glycogen by amylo-l,4-1,6 glucosidase followed by determination of the glucose released by the glucose oxidase method. Protein concentration was determined using the Bio-Rad assay (Bio-Rad, Munich, Germany), with bovine serum albumin as standard.
Calculations. Glucose turnover was calculated by dividing the tracer infusion rate by the plasma glucose specific activity under steady-state conditions. In control rats (basal state), endogenous glucose production was considered equal to the rate of glucose appearance, glucose input from the digestive tract being negligible. In these rats glucose utilization equalled glucose production. During insulin infusions, glucose production was calculated by subtracting the steady-state glucose infusion rate from the glucose turnover rate to obtain glucose utilization values. The urinary glucose excretion rate was calculated by dividing the tracer infusion rate by [3H] glucose specific activity in urine. Glucose clearance was measured by dividing the glucose utilization rate by the plasma glucose concentration. measured in the presence of 7.2 mmol/1 G 6-P [18] and expressed as nmol of UDP-glucose incorporated into glycogen per min and per mg of protein. Pyruvate dehydrogenase (PDH) activity was measured in isolated mitochondria. Mitochondria from skeletal muscle were prepared extemporaneously and PDH activity immediately measured. Muscle (300 mg fresh tissue) was disrupted in sucrose buffer (0.25 mmol/1 sucrose/5 mmol/1 Tris-HC1/2 mM EGTA, pH 7.4) containing 50 mmol/1 NaF and 10 mmol/1 sodium dichloroacetate (DCA) as inhibitors of PDH kinase and PDH phosphatase. After differential centrifugation, mitochondria were divided into two portions. One was resuspended in KC1 medium (120 mmol/ 1:KC1/20 Tris-HC1/5 potassium phosphate/2 EGTA pH 7.4) containing DCA and NaF, to inhibit the active/inactive enzyme interconversion, and then pelleted by centrifugation (10,000 x g), immediately frozen in liquid nitrogen and used for the determination of the PDH complex activity at the time of killing (PDHa). The other mitochondrial portion was washed of NaF and DCA by dilution (100 volumes of sucrose buffer free of inhibitors) and then pelleted by centrifugation. These mitochondria were then incubated for 30 min at 30 ~ in KC1 medium containing 10 ~tmol/1 CCCP (an uncoupler of oxidative phosphorylation) to obtain full reactivation of PDH by depleting mitochondrial ATR Mitochondria were pelleted
Statistical analysis
Results are presented as mean + SEM Statistical significance of differences was analysed by using Student's t-test for unpaired values.
Results

Post-absorptive values
Substrate and hormone concentrations. The STZ injection was followed by a transient phase of hyperinsulinaemia and hypoglycaemia, which was maximal at the sixth hour. Insulinopenia and hyperglycaemia developed progressively after the 18 th hour. At the 30 th hour after STZ injection (i.e. 12 h after the onset of hyperglycaemia), plasma insulin was 5 + 1 ~U/ml and blood glucose 17.5 + 0.5 mmol/1. All rats were glucosuric but not ketonuric. The peripheral plasma NEFA and glucagon levels were not significantly higher in diabetic than in control rats (Fig. 1) . The Table 1 . Blood glucose and plasma insulin concentrations and glucose turnover rates in control and STZ-diabetic rats in the basal state and during euglycaemic hyperinsulinaemic clamp at low and high plasma insulin levels Results are mean values + SEM of 5 to 10 determinations in control rats and 9 to 13 determinations in diabetic rats ap < 0.05; bp < 0.01 from control rats (operated sham-injected rats)
Cp < 0.05; ap < 0.01 between glucose production and utilization at the lower and higher insulin plateau diabetic rats lost 8.2 % of their initial body weight over 30 h, but kept normal motor activity. In similar STZ-diabetic rats, not subjected to the clamp studies, an 8-day follow-up demonstrated the persistence of severe insulinopenia, and a progressive rise in plasma glucagon and NEFA levels. Rats were ketonuric after the third day and none of them recovered from diabetes.
Glucose kinetics. In basal post-absorptive conditions, the endogenous glucose production rate was significantly higher in diabetic than in control rats: 36.6 + 3.0 vs 24.4 + 2.5 mg. kg -1 9 min -1, p < 0.01. The basal post-absorptive glucose utilization rate was similar in hyperglycaemic diabetic and in normoglycaemic control rats: 29.6 + 1.7 mg. kg -1. min ,a vs 24.4 + 2.5 mg. kg -1 9 min -1 ( Table 1) . These relatively high rates are consistent with the muscular activity in awake rats. The urinary glucose excretion rate was 6.7 + 2.7 rag. kg -1-min -1 in hyperglycaemic post-absorptive diabetic rats. The glucose clearance rate, an index of the capacity for glucose utilization independently of plasma glucose concentration, was decreased by 50% in diabetic rats: 9.4+ 1.3 mg. kg -1 9 min -1 vs 26.5 + 1.9 mg. kg -1 9 rain -1 ( Table 1) .
Euglycaemic clamp. Normoglycaemia was reached
30 min after the start of insulin infusion in diabetic rats during the clamp experiments and blood glucose levels then remained steady and in the normal range until the end of the experiments. During the last 60 min of the clamps, urinary glucose excretion was negligible in all diabetic rats (0.9+0.3 mg. kg -1 9 min-X). At the lower insulin infusion rate, plasma insulin concentrations were close to 200 ~tU/ml. At the higher infusion rate, plasma insulin concentrations were close to 2500 vU/ml. Glucose production was totally suppressed at plasma insulin levels of 200 ~tU/ml in control rats, whereas a significant glucose production persisted in diabetic rats (6.7 + 1.9 mg. kg -1. min -1, i.e. 20 % of basal glucose production). Glucose production was also totally suppressed in diabetic rats at plasma insulin levels of 2500 ~tU/ml. The glucose utilization rate was increased to a similar extent at plasma insulin levels of 200 ~tU/ml in control and diabetic rats. However, maximal glucose utilization was significantly lower in diabetic than in control rats at plasma insulin levels of 2500 ~tU/ml (Table 1) .
Glucose utilization in skeletal muscles and adipose tissues. In basal conditions, glucose utilization indices in skeletal muscles, heart and adipose tissues were similar in normoglycaemic control and hyperglycaemic diabetic rats (Table 2 ).
In clamp experiments at plasma insulin levels of 200 ~tU/ml, insulin resistance was detected in some tissues (diaphragm, white and brown adipose tissues) of normoglycaemic diabetic rats but not in other tissues (heart, soleus, extensor digitorum longus). In contrast, a significant insulin resistance was detected in all tissues of normoglycaemic diabetic rats at plasma insulin levels of 2500 ~tU/ml, i. e. under the conditions of maximal insulin effect (Table 2) .
Glycogen concentration and enzyme activities in liver and muscles. Liver glycogen concentrations were significantly lower in post-absorptive diabetic than in control rats: 10.5 + 0.5 vs 18.2 + 0.8 mg/g wet tissue (p < 0.05). Glycogen concentrations in non-operated fed adult rats were 30 mg/g. The cytosolic PEPCK and G 6-Pase activities were markedly increased in liver of diabetic rats. PEPCK activity was 30.8 + 4.0 in diabetic rats vs 8.2 + 0.8 mg. kg -1 9 min -1 (p < 0.001) Results are means + SEM of six different rats in each group. ap < 0.05 bp < 0.01 from control rats in control rats and G 6-Pase activity was 7.3 + 0.3 in diabetic rats vs 4.8 + 0.8 ~tmg 9 kg -1 9 min -1 in control rats (p < 0.05).
Glycogen concentrations in soleus muscles were similar in control and STZ-diabetic rats: 14.6 + 0.7 and 13.9 + 0.6 mg/g wet tissue, respectively. The total PDH activity was also similar in both groups: 46 + 10 U/mg protein (54 % in the active form) in the diabetic rats vs 50 + 10 U/mg (56 % in the active form) in control rats. The total glycogen synthase activity was also similar: 5.4 + 0.3 mg. kg -1. min -~ (67 % in the active form) in diabetic rats, vs 5.7 + 0.2 mg. kg -1 9 min -1 (56 % in the active form) in control rats.
Discussion
Recent-onset insulinopenia in STZ-diabetic rats was associated with glucose overproduction in the basal (hyperglycaemic) state. Under euglycaemic hyperinsulinaemic conditions, glucose overproduction was not fully suppressed at a plasma insulin level of 200 ~U/ml (in contrast to control rats), but was entirely suppressed at plasma insulin levels of 2500 ~tU/ ml. The liver glycogen concentrations were relatively low in all post-absorptive rats, presumably due to recent surgery and the 8-h fast; nevertheless liver glycogen concentrations were significantly lower in diabetic than in control rats. This was probably due to the insulin-deficient state of diabetic rats. However, a direct glycogenolytic effect of STZ on the liver cannot be excluded. Thus, it is unlikely that sustained glucose overproduction in post-absorptive diabetic rats originates from their limited liver glycogen stores. It is more likely that sustained glucose overproduction in post-absorptive diabetic rats originates from an increased hepatic gluconeogenesis as suggested by the increases in PEPCK and G 6-Pase activities in liver of recent-onset diabetic rats. An increase in gluconeogenesis [21] [22] [23] and in the activities of PEPCK [24, 25] and G-6-Pase [26, 27] has already been reported in the liver of fed, long-term diabetic rats while hormone-stimulated glycogenolysis was decreased [28] . In the present study, insulinopenia could have played a determinant role in these phenomena, in association with the mild concomitant hyperglucagonaemia [25, 26] . The incomplete suppression of glucose production at plasma insulin levels of 200 ~xU/ml in euglycaemic clamps in recentonset diabetic rats does not necessarily indicate the presence of a state of liver insulin resistance. Indeed, it is well known that gluconeogenesis is significantly less sensitive to the inhibitory effect of insulin than glycogenotysis [29] [30] [31] . As gluconeogenesis is responsible for a larger proportion of liver glucose production in diabetic than in control rats, the incomplete suppression of glucose production at plasma insulin levels of 200 ~U/ml could be due to the increase in gluconeogenesis rather than to a state of insulin resistance. It must be stressed, however, that we did not specifically measure the sensitivity of gluconeogenesis to insulin in these diabetic rats.
The glucose utilization rate in basal conditions was normal in diabetic rats, owing to the concomitant hyperglycaemia. Indeed, hyperglycaemia increases whole-body glucose utilization, independent of the prevailing insulin level [31, 32] . However, as glucose clearance, an index of the capacity for glucose utilization independently of plasma glucose concentration, was decreased in diabetic rats, this indicated that the capacity for glucose utilization was already reduced, due to the state of insulinopenia. Insulin resistance was also detectable in different tissues during the euglycaemic hyperinsulinaemic clamp. In adipose tis-sue, insulin resistance was already significant at plasma insulin levels of 200 ~U/ml, which underlined the exquisite sensitivity of adipose tissue to insulin.
4. Whole body and muscle insulin resistance were detectable only at plasma insulin levels of 2500 ~U/ml. 5. The mechanisms responsible for the decrease in maximal insulin effects on muscles and adipose tissues in diabetic rats are still unclear. Neither insulin recep-6. tor numbers nor their state of phosphorylation have been reported to be affected in muscle and adipose 7. tissue of diabetic rats [33, 34] . We have previously reported that the expression of Glut-4 and the activity of hexokinase HKII were unaltered in muscles of recent-onset diabetic rats [35] . The insulin-stimulated 8. phosphorylation of insulin receptor substrate (IRS)-1 and the activation of phosphatidylinositol (PI) 3-kinase are increased, not decreased, in muscle from 9. STZ-diabetic rats [36] [37] [38] . Thus the defect in insulin action seems to be located at a step distal to the insulin receptor activation.
A defect in insulin-induced activation of the glycogen synthase, resulting in lower glycogen synthesis in muscles, could be the predominant cause of insulin resistance. Indeed, insulin increases the percentage of active form of glycogen synthase in skeletal muscle, whereas total activity remains unchanged [39] [40] [41] [42] .
In the present study, the total activity of glycogen synthase and PDH and the percent of their active forms were normal in the post-absorptive state, indicating that recent-onset diabetes does not induce a decrease in the synthesis of these two proteins. Unfortunately, the phosphorylation state of glycogen synthase and PDH (active forms) in muscles of diabetic rats was not assessed at the end of clamp experiments. The most likely explanation for the early defect in maximal insulin-stimulated glucose utilization observed in the present study, would be a decrease in insulin-stimulated phosphorylation state of glycogen synthase and PDH (active forms) in muscles of diabetic rats. This needs to be determined in further experiments.
